Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
Clinical trial NCT04989218 · TERMINATED
Trial details
- NCT number
- NCT04989218
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2024-03-20
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.